Company Overview
Snapshot
Founded in January 2021 by Carmit Lev Solash, IntoSleep operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its AI-powered solution for insomnia treatment.
Business overview
IntoSleep is dedicated to transforming insomnia treatment through an integrated digital health solution that leverages AI, biofeedback, and neuroscience. The company's core technology involves a proprietary finger sensor and a mobile application that tracks physiological data, analyzes individual sleep patterns, and employs an AI algorithm to deliver personalized biofeedback and neuroscience feedback. This approach aims to address the root causes of insomnia, enabling users to fall asleep faster and achieve better sleep. IntoSleep serves both B2C and B2B2C markets, operating within the digital healthcare, digital therapeutics, and wellness sectors.
Strategic signal
In May 2023, IntoSleep was featured in an Israel21c article highlighting its innovative approach to curing insomnia using biofeedback and neuroscience. This coverage signals growing recognition of the company's technology and its potential to disrupt traditional sleep disorder treatments, indicating early market validation for its personalized, real-time interventions.
Company Intelligence Q&A
- What is IntoSleep's primary mission?
- IntoSleep's primary mission is to revolutionize insomnia treatment by integrating AI, biofeedback, and neuroscience to provide personalized, real-time solutions for individuals.
- What technology does IntoSleep utilize?
- IntoSleep utilizes a proprietary finger sensor and a mobile application that tracks physiological data, analyzes individual sleep patterns, and employs an AI algorithm to create personalized biofeedback and neuroscience feedback.
- When was IntoSleep founded?
- IntoSleep was founded in January 2021.
- Who is a key founder of IntoSleep?
- Carmit Lev Solash is a co-founder and CEO of IntoSleep.
- What market segments does IntoSleep target?
- IntoSleep targets both Business-to-Consumer (B2C) and Business-to-Business-to-Consumer (B2B2C) market segments with its digital health solution.